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OBJECTIVES Our purpose was to assess noninvasive imaging in detection of subclinical atherosclerosis and
to examine novel invasive modalities to describe prevalence and temporal changes in putative
characteristics of “high-risk” plaques.
BACKGROUND Conventional coronary imaging cannot identify “high-risk” lesions.
METHODS Conventional (quantitative angiography and intravascular ultrasound [IVUS]) and novel
imaging (IVUS-based palpography and gray scale echogenicity) were performed at baseline
and 6 months later in 67 patients with diverse clinical presentations. Different imaging
techniques were compared within a common segment defined by multislice computed
tomography (MSCT).
RESULTS Compared with IVUS, the sensitivity, specificity, and positive and negative predictive value
of MSCT for detecting significant plaque was 86%, 69%, 90%, and 61%, respectively. In
coronary arteries with 50% stenosis, there were no temporal changes in luminal and plaque
dimensions measured by quantitative coronary angiography or IVUS; however, a significant
reduction in abnormal strain pattern was detected on palpography (density high strain
spots/cm: 1.6  1.5 vs. 1.2  1.4, p  0.0123. These changes were mainly related to
significant changes in patients who presented with ST-segment elevation myocardial
infarction. The assessment of plaque echogenicity showed no temporal changes. There were
no correlations between circulating biomarkers and quantifiable imaging parameters.
CONCLUSIONS Mild angiographic disease is associated with large atherosclerotic plaques on MSCT.
Conventional invasive coronary imaging reveals static luminal and plaque dimensions on
standard medical therapy with plaque hypoechogenicity remaining unchanged over the
6-month period. By contrast, palpography measurements of strain correlate with clinical
presentation and significantly decrease on standard medical therapy. Novel imaging modal-
ities, such as palpography, might provide insights into plaque biology and might eventually
serve as intermediate end points in interventional trials. (J Am Coll Cardiol 2006;47:
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.09.0751134–42) © 2006 by the American College of Cardiology Foundation
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ptherosclerosis is a systemic disease in which the clinical
equelae only weakly correlate with its extent or severity.
urthermore, sudden death or acute coronary syndromes are
requently the first manifestation of previously subclinical
therosclerosis, and the majority of such events (i.e., 60% to
0%) occur as a result of plaque rupture at sites with noncritical
uminal narrowing (1–5). Pathologic studies have correlated
pecific coronary plaque characteristics with fatal ischemic
From the *Erasmus Medical Center, Rotterdam, the Netherlands; †Cardialysis,
ottterdam, the Netherlands; ‡GlaxoSmithKline, Philadelphia, Pennsylvania; and
Thomas Jefferson University, Philadelphia, Pennsylvania. This study was supported
y a research grant from GlaxoSmithKline, Philadelphia, Pennsylvania.p
Manuscript received June 12, 2005; revised manuscript received August 31, 2005,
ccepted September 26, 2005.vents, but conventional imaging techniques, such as quan-
itative angiography and quantitative intravascular ultra-
ound (IVUS), cannot reliably identify high-risk, rupture-
rone, plaques prospectively (6). Thus, development of
ovel coronary imaging modalities to detect structural and
ompositional plaque characteristics has been the subject of
ntensive preclinical and clinical research (7,8). In parallel
ith the advances in novel invasive imaging, noninvasive
ultislice computed tomographic angiography (MSCTA)
as matured to the extent that it can reliably identify
ow-limiting coronary lesions in relatively unselected
atients.
The aim of this study was four-fold: 1) to determine theotential of MSCTA in the detection of subclinical, non-
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March 21, 2006:1134–42 The IBIS Studyow limiting coronary atherosclerosis; 2) to assess the preva-
ence of high-risk characteristics in such plaques with two
ovel IVUS-based imaging modalities (palpography and
chogenicity plaque characterization); 3) to assess temporal
hanges in IVUS-based plaque characteristics of high-risk
esions; and 4) we attempted to relate changes in imaging
arameters to changes in systemic biomarker levels.
ETHODS
tudy design and patient selection. This was a prospec-
ive, observational, single-center pilot study. The study
esign has been described in detail elsewhere (9). Briefly,
atients with stable angina, unstable angina, non–ST-
egment elevation, or ST-segment elevation myocardial
nfarction (STEMI), referred for percutaneous coronary
ntervention (PCI), were eligible for inclusion. Major clin-
cal exclusion criteria included significant renal dysfunction
creatinine 2 mg/dl), prior coronary intervention in the
egion of interest (ROI), life expectancy 1 year, or factors
hat made follow-up difficult. Major imaging-related exclu-
ion criteria included coronary anatomy that precluded safe
VUS examination of a suitable ROI or criteria that
recluded acquisition of diagnostic noninvasive angio-
raphic images (irregular heart rhythm or inability to hold
reath for 20 s). Between March 2003 and November 2003,
0 consecutive patients were enrolled, and follow-up was
ompleted in summer 2004. The study vessel was preferably
non-intervened artery. At the discretion of the operator, a
econd artery could be studied. The ROI was defined on the
asis of MSCTA, using landmarks, such as branches or the
essel origin. At six months follow-up, patients underwent
epeat invasive imaging. The medical ethics committee of
he Erasmus Medical Center Rotterdam approved the study
rotocol, and all patients provided written informed
onsent.
uantitative coronary angiography and IVUS. Quanti-
ative angiographic analyses were performed by a core
aboratory (Cardialysis, Rotterdam, the Netherlands) with
he use of edge-detection techniques (CAAS II, Pie Med-
Abbreviations and Acronyms
EEM  external elastic membrane
HDL-C  high-density lipoprotein cholesterol
IBIS  Integrated Biomarker and Imaging Study
IVUS  intravascular ultrasound
LDL-C  low-density lipoprotein cholesterol
MI  myocardial infarction
MSCT  multislice computed tomography
MSCTA  multislice computed tomographic angiography
PCI  percutaneous coronary intervention
PV  plaque volume
ROC  ROtterdam Classification
ROI  region of interest
STEMI  ST-segment elevation myocardial infarctioncal, Maastricht, the Netherlands). Mean and minimum cuminal diameters and diameter stenosis were measured
n at least two, preferentially orthogonal, projections and
veraged.
The IVUS was performed with commercially available
atheters (30 MHz, Ultracross, or 40 MHz, Atlantis SR
ro, Boston Scientific, Santa Clara, California) using stan-
ard procedures with an automated pullback device (0.5
m/s) (10). Data were stored on videotape, transformed
nto the Digital Imaging and Communication in Medicine
DICOM) image standard, and archived. Quantitative
nalysis was performed by the core laboratory with validated
oftware (Curad, version 3.1, Wijk bij Duurstede, the
etherlands) and retrospective image-based gating (11).
he borders of the external elastic membrane (EEM) and of
he lumen were traced. The enclosed area was defined as the
oronary plaque plus media area (subsequently referred to as
laque area). Significant plaque was defined as a plaque that
ccupied 50% or more of the cross-sectional vessel area
ircumscribed by the EEM. Other IVUS measurements
ncluded length of the ROI, lumen volume, and vessel
olume. Plaque volume (PV) was calculated as vessel volume
inus lumen volume. The interobserver variability was
etermined by re-analyzing the baseline and follow-up
VUS recordings of 16 patients by a different core lab
nalyst. Sixteen patients (32 recordings) were randomly
elected among recordings that fulfilled the following two
riteria: 1) ROI 30 mm long, and 2) both pullbacks were
erformed with the same type of IVUS catheter (30 MHz
atheter).
ovel IVUS-based plaque imaging: echogenicity. We
sed a computer-aided, gray-scale value analysis program
or plaque characterization (12). On the basis of the mean
ray level (brightness) of the adventitia, plaque was classified
s brighter (hyperechogenic) or less bright (hypoechogenic)
han the adventitia. Calcified plaque was defined as plaque
righter than the adventitia with associated acoustic shad-
wing. The variables measured in the previously defined
OI included hypoechogenic PV and hyperechogenic PV
mm3) and relative plaque echogenicity, calculated as (hy-
oechogenic PV/sum of hypoechogenic and hyperechogenic
V) 100. For the comparison with MSCT, plaque within
he ROI was considered calcified if it contained calcium in at
east two consecutive cross-sections corresponding to an
VUS segment with a length of at least 0.5 mm.
ovel IVUS-based plaque imaging: palpography. Pal-
ography is an IVUS-based technique that assesses the local
echanical properties of the coronary plaque. The tech-
ique measures the relative displacements of backscattered
adiofrequency signals, recorded during IVUS acquisition,
t two different blood pressure levels to detect differences in
eformability or strain of various plaque components. As
uch, lipid-rich plaques will deform more and thus show a
igher strain value compared with calcified or fibrous
laques (13). Palpography data were acquired during an
VUS pullback (1 mm/s) with a commercially available
atheter (20 MHz Jovus Avanar, Volcano, Rancho Cor-
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The IBIS Study March 21, 2006:1134–42ova, California). With previously described and validated
ethodology, plaque strain values were assigned a ROtter-
am Classification (ROC) score ranging from 1 to 4 (ROC
: 0% to 0.6%; ROC 2: 0.6% to 0.9%; ROC 3: 0.9% to
1.2%; ROC 4: 1.2%) (13–16). The parameters mea-
ured included the number of ROC 3 or 4 spots in the ROI
nd the density of ROC 3/4 spots, defined as the total
umber of ROC 3 and 4 scores that were counted in all
ross sections that were acquired at 1-mm intervals in the
hole ROI. This number was divided by the length of the
OI and multiplied by 10 to normalize to the pullback length.
SCTA. All scans were performed on a 16-row detector
canner (Sensation 16, Straton, Siemens, Forchheim, Ger-
any). The scan protocol and image reconstruction param-
ters were recently published (17). The dataset with least
otion artifacts was loaded on an off-line workstation
Leonardo, Siemens) and the ROI identified on multiplanar
econstructions, on the basis of anatomic landmarks. Data-
ets were loaded on a semi-automated vessel-tracking soft-
are program and a central lumen line created throughout
he ROI. Ten through 30 cross sections were reconstructed
rthogonal to the center of the lumen and analyzed inde-
endently by two observers. Disagreements were resolved by
onsensus. Plaque was defined as an abnormal mass within
he artery wall, clearly distinguishable from epicardial fat
nd the coronary lumen. On the basis of manually measured
aximal thickness, plaques were classified as small (1
m), medium (1 to 2 mm), or large (2 mm). Calcification
as defined by the presence of high-density components
igure 1. Flow chart detailing number of patients at baseline and follow-
p. Values in parentheses reflect number of vessels examined with different
maging modalities. IVUS  intravascular ultrasound; QCA  quantita-
ive coronary angiography.130 Hounsfield units). ripoprotein levels and biomarkers. Plasma concentra-
ions of total cholesterol, high-density lipoprotein choles-
erol (HDL-C), and triglycerides were measured in the local
aboratory. The Friedewald formula was used to derive
ow-density lipoprotein cholesterol (LDL-C) levels (18).
lood samples for additional biomarker analysis were stored
t 70°C. Serum C-reactive protein (Diagnostic Systems
aboratories, Webster, Texas), plasma interleukin 6, and
umor necrosis factor-alpha (R & D Systems, Minneapolis,
innesota) were measured in the Human Biomarker Cen-
er (GlaxoSmithKline, Philadelphia, Pennsylvania) on the
asis of protocols provided by the manufacturer. Lipopro-
ein associated phospholipase A2 activity assay was mea-
ured by the proportional release of aqueous 3H acetate
esulting from the enzymatic cleavage of the 3H acetyl-
latelet activating factor substrate (100 mol/l). N-terminal
able 1. Baseline Characteristics of Patients With Invasive
ollow-Up Evaluation
Demographics and Clinical History
Patients
(n  67)
ale 57 (85)
ge (yrs) 58  11
revious myocardial infarction 27 (40)
revious coronary bypass surgery 1 (1)
revious percutaneous coronary intervention 11 (16)
istory of diabetes 6 (9)
istory of stroke 1 (1)
amily history of coronary disease 36 (54)
ypertension* 29 (43)
ypercholesterolemia† 57 (85)
revious smoker 23 (34)
urrent smoker 26 (39)
edication at inclusion
Aspirin 59 (88)
Clopidogrel 38 (57)
ACE-I/AT2 20 (30)
Beta-blocker 44 (66)
Statin therapy 48 (72)
edication at 6 months’ follow-up
Aspirin 61 (91)
Clopidogrel 63 (94)
ACE-I/AT2 34 (51)
Beta-blocker 50 (75)
Statin therapy 66 (99)
linical status at enrollment
Stable angina 32 (48)
Unstable angina or non–STEMI 21 (31)
STEMI 14 (21)
xtent of disease‡
Non-significant disease 4 (6)
Single-vessel disease 36 (53.7)
Two-vessel disease 21 (31.3)
Three-vessel disease 3 (4.5)
Left main stem (plus two-vessel) disease 3 (4.5)
ategorical data are presented as n (%) and continuous data as mean values  SD.
Blood pressure 160/95 mm Hg or treatment for hypertension. †Total cholesterol
215 mg/dl or treatment for hypercholesterolemia. ‡Significant disease was defined
s 50% (visual estimate) stenosis in a major epicardial vessel or in branches 2.5
m diameter.
ACE-I  angiotensin-converting enzyme inhibitor; AT2  angiotensin-II
eceptor antagonist; STEMI  ST-segment elevation myocardial infarction.
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March 21, 2006:1134–42 The IBIS Studyro brain natriuretic peptide was measured with use of a
wo-site electrochemiluminescent assay.
efinition of events and follow-up for major adverse
ardiac events. The occurrence of major adverse cardiovas-
ular events was assessed after the procedure, at discharge,
nd at three and six months, as were the individual com-
onents: death, myocardial infarction (MI), revasculariza-
ion by PCI or coronary artery bypass graft surgery, hospital
tay for ischemia and/or anginal symptoms, and stroke. The
iagnosis of MI was consistent with the American College
f Cardiology/European Society of Cardiology definition
19).
tatistical analysis. Discrete variables are presented as
ounts and percentages. Continuous variables are presented
s means  SD, unless otherwise indicated. Comparisons
etween quantitative outcomes were performed with use of
catter plots and linear regression analysis (regression coef-
cient). When appropriate, biomarker analyses were per-
ormed after natural logarithmic transformation. Correla-
ions between imaging end points and circulating biomarkers
ere assessed, and univariate Pearson correlation coefficients
ere calculated. Comparisons among patient subgroups,
rouped by clinical presentation, with findings on palpography
nd on echogenicity, were performed at both vessel and
atient level. In the latter case, the imaging findings from
wo ROIs in the same patient were averaged. Differences in
eans among groups were analyzed by a two-sample t test.
value p  0.05 (two-sided) was indicative of statistical
ignificance. No formal hypotheses were tested in this
xploratory study; therefore p values are given as such,
ithout any correction for multiplicity of testing. Statistical
nalyses were performed with the Statistical Analysis System
able 2. Changes in Lipid Parameters
Total Cholesterol, mg/dl LDL
ntire cohort (n  64)
Baseline 176.8  48
Follow-up 171.1  31.8
Change 5.9  51
p value NS
TEMI (n  13)
Baseline 210  37.5
Follow-up 166.7  34.6
Change 40.9  39.2
p value 0.003
A or non–STEMI (n  21)
Baseline 167.1  45.2
Follow-up 169.9  26.6
Change 7.5  54
p value NS
table angina (n  30)
Baseline 169.2  49
Follow-up 174.2  34.4
Change 3.6  47.8
p value NS
DL  high-density lipoprotein; LDL  low-density lipoprotein; STEMI  ST-oftware version 8.2 (SAS Institute, Cary, North Carolina).
L
sESULTS
atient population. A flow diagram detailing the number
f patients undergoing multimodality coronary imaging is
resented in Figure 1. Sixty-seven patients underwent serial
nvasive imaging of non-culprit segments of coronary artery
t baseline and 196  19 days later. Nine patients had one
r both IVUS recordings that were not analyzable, owing to
rtifact or use of an incorrect scale. An additional three
atients could not be analyzed for IVUS echogenicity,
wing to extensive calcification overshadowing a large part
f the adventitia, which is used as a reference for the
nterpretation of gray-scale values of surrounding tissue.
easons for inaccurate palpogram readings (n  18) were
elated to extensive catheter motion during data acquisition.
aseline characteristics of patients who completed the study
re shown in Table 1. They were comparable to those of the
ntire cohort of 84 patients enrolled at baseline (not shown).
lmost all patients (99%) received treatment with a statin
ithin the six-month study period, mainly as a result of
tarting treatment in the group who presented initially with
esterol, mg/dl HDL Cholesterol, mg/dl Triglycerides, mg/dl
 44.7 39.7  13.7 143.1  83.9
 29.6 44.1  14.4 165.9  82.3
 44.6 4.3  9 21.1  79.9
S 0.001 0.008
 32.8 43.5  12 143.4  68.6
 30.9 39.9  10.3 162.5  67.6
 41.1 3.3  6.1 27.2  58.5
.006 NS NS
 36.4 36.8  11.6 144.5  81
 25.1 47.2  15.7 152.7  87.1
 39.6 9.6  6.5 5.9  80.7
S 0.001 NS
 49 40  15.7 142  94
 32.4 44.1  15.3 176.1  87.4
 46.3 4.5  9.2 28.1  89.5
S 0.026 0.014
t elevation myocardial infarction; UA  unstable angina.
able 3. Accuracy of Multislice Computed Tomography
or the Detection of Significant Coronary Plaque*:
omparison With IVUS for the Entire Region of Interest
nd for its 5-mm Subsegments
Entire Region
of Interest
5-mm
Subsegments
ensitivity 44/51 (86, 74–93) 136/185 (74, 67–79)
pecificity 11/16 (69, 44–86) 140/192 (73, 66–79)
ositive predictive value 44/49 (90, 78–96) 136/188 (72, 66–78)
egative predictive value 11/18 (61, 39–80) 140/189 (74, 67–80)
alues are n (%, 95% confidence interval). *Significant plaque on intravascular
ltrasound (IVUS) was defined as mean plaque area obstruction ([Vesselarea Chol
113
104.5
10.6
N
145
102.6
36.1
0
107.8
100.2
4.6
N
102.7
108.2
2.3
Numenarea/Vesselarea]  100) 50%, or the presence of calcium on two consecutive
lices on intravascular ultrasound (IVUS).
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The IBIS Study March 21, 2006:1134–42TEMI (treatment started in 13 of 14 STEMI patients).
ean total cholesterol, LDL-C, HDL-C, and triglyceride
alues for patients who completed the study are presented in
able 2.
SCTA versus IVUS at baseline. The MSCTA and
VUS were compared, at baseline, in 61 patients (67
essels). The sensitivity and specificity of MSCTA to detect
ignificant plaque identified on IVUS (50% EEM area
bstruction or the presence of calcification on two consec-
tive slices) was calculated for the entire ROI and for 5-mm
ub-segments (Table 3). The sensitivity, specificity, and
ositive and negative predictive values of MSCTA for
etection of any significant plaque was 86%, 69%, 90%, and
1%, respectively. The sensitivity of MSCTA to detect
laque was 60% (30 of 50) for small (1 mm), 76% (80 of
05) for medium (1 to 2 mm), and 79% (26 of 33) for large
2 mm) plaques.
eproducibility of IVUS measurements. Interobserver
ariability for IVUS analysis (n  32 pullbacks) showed no
ystematic error and good reproducibility. Mean differences
n area (mm2) measurements were: 0.04  0.56 for EEM,
.02  0.50 for lumen, and 0.06  0.59 for plaque. The
ean difference in PV (mm3) was 2.43  22.
onventional imaging: quantitative coronary angiogra-
hy and IVUS. There were no statistically significant
hanges in the angiographic variables measured in the ROI
Table 4). Likewise, IVUS-derived measurements remained
nchanged in matched segments (Table 5). Figure 2 illus-
rates the spread of the individual data points for PV.
hen patients were grouped according to initial diagnosis
i.e., STEMI, unstable angina, stable angina), there were no
ignificant changes in either angiographic or IVUS mea-
urements between baseline and follow-up (data not
hown).
ovel IVUS-based imaging. Temporal changes in plaque
haracteristics on the basis of IVUS-based palpography and
chogenicity are shown in Tables 5 and 6. At baseline, the
Table 4. Quantitative Angiographic Parameter
Length
(mm)
Mean D
(m
Entire cohort (n  67)
Baseline 27.2  13.1 2.78
Follow-up 27.2  13.1 2.84
Change 0.0  2.5 0.06
p value NS N
Values are mean  SD.
able 5. Quantitative IVUS (n  58) and Echogenicity (n  55
Variable
Length
(mm)
Lumen Volume
(mm3)
Vessel Volu
(mm3)*
aseline 29.3  14.4 285  161 481  25
ollow-up 29.2  14.2 279  161 469  24
hange 0.1  1.6 7  52 12  61
value NS NS NSalues are mean SD. *Vessel volume denotes the volume circumscribed by the external ela
cholucent media. ‡Hypo volume  hypoechogenic plaque volume. §Hyper volume  hypredominant plaque component was hypoechogenic tissue
91.6% of PV). There was no significant change in the
bsolute volume of hypoechogenic or hyperechogenic
laque over the course of the study. On palpography, both
he absolute number of high-strain spots (grade 3/4) in the
OI (p  0.009) and their density per cm (p  0.012)
ecreased significantly between baseline and follow-up.
his decrease in the overall population was largely driven by
hanges in the subgroup of patients with STEMI; this
roup had both the highest number of high-strain spots at
aseline and the most marked relative decrease during
ollow-up, compared with patients with other clinical pre-
entations. At 6-month follow-up, the density of high-
train spots (1.2  1.4/cm) was comparable among clinical
ubgroups. Representative imaging findings are presented in
igure 3.
orrelation of biomarkers with imaging techniques. Not
urprisingly, several inflammatory mediators (C-reactive
rotein, interleukin-6, lipoprotein-associated phospholipase
2) and a marker of hemodynamic stress (NT-proBNP)
ecreased over time, particularly in patients presenting with
cute coronary syndromes. There were no significant corre-
ations noted between circulating biomarkers and imaging
arameters (data not shown). Among lipid parameters (total
holesterol, LDL-C, HDL-C, and triglycerides), a correla-
ion with the change in IVUS-derived plaque area was only
oted for the change in HDL-C (Pearson correlation
oefficient 0.37, p  0.05, data not shown).
dverse events. One patient died two weeks after inclu-
ion, because of a second MI. All imaging procedures were
erformed without complications.
ISCUSSION
he major findings of the study were four-fold. First, with
VUS as a gold standard, noninvasive MCSTA can identify
therosclerotic plaque, in vessels with only minimal angio-
67)
ter Minimal Diameter
(mm)
Diameter Stenosis
(%)
2.31  0.6 25  11
2.38  0.7 25  11
0.06  0.4 0.0  8
NS NS
ameters
Total Plaque Volume
(mm3)†
Hypo Volume
(mm3)‡
Hyper Volume
(mm3)§
195  117 171  104 15  11
190  107 177  98 12  14
5.2  33 6  53 3  13
NS NS NSs (n 
iame
m)
 0.6
 0.8
 0.4
S) Par
me
0
3stic membrane. †Total plaque volume denotes Vesselvolume Lumenvolume including
erechogenic plaque volume.
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March 21, 2006:1134–42 The IBIS Studyraphic disease, with high sensitivity and moderate speci-
city. Second, further investigation of such plaque with
ovel IVUS-based imaging techniques (palpography and
chogenicity) showed that features potentially indicative of
ulnerable plaques are both widespread and highly prevalent.
hird, although conventional imaging with quantitative coro-
ary angiography and IVUS demonstrates no significant
hanges in lumen or plaque dimensions, the biomechanical
roperties of the plaques, assessed by palpography, showed
ignificant changes over a relatively short period. Finally,
irculating levels of measured biomarkers showed no signif-
cant correlations with focal imaging end points identified
y conventional and novel imaging modalities.
ubclinical atherosclerosis: role of noninvasive imaging.
he development of noninvasive angiography with
SCTA can be used to reliably identify significant epicar-
ial coronary atherosclerosis (20). Recent studies have
hown its potential for detecting non-obstructive coronary
laques in highly selected patients (21,22). Our results
xtend these findings by showing that non-obstructive
oronary plaque can be detected, in an arbitrarily selected
OI, with moderately high sensitivity and specificity in a
roader patient population; however, when examined in
ore detail, with novel invasive techniques, we found that
utative “high-risk” characteristics (i.e., hypoechogenic
laques with a high-strain pattern) were very common. This
bservation provides additional arguments to support rec-
mmendations discouraging the indiscriminate use of non-
nvasive coronary imaging to detect subclinical atheroscle-
osis at the present time (23).
ubclinical atherosclerosis: insights from novel invasive
echniques. We have previously validated the potential of
alpography to identify thin-capped fibroatheromas in vitro
13,14,24,25). Subsequently, we showed that the number of
igh-strain spots in culprit epicardial vessels was correlated
ith clinical presentation (16). The present study extends
hese findings by demonstrating that, within arbitrarily
igure 2. Bland-Altman plot of the intravascular ultrasound data on
laque volume. The green (top) and blue (bottom) lines indicate the
orders of 2  SD.elected segments of non-culprit vessels, high-strain areas
1ere quite common, despite only mild angiographic disease.
he most marked changes occurred in patients with an
cute MI, most of who were statin-naïve (93%) at the time
f the initial presentation. Although acute MI patients had
higher extent of high strain spots, all subgroups were
omparable six months later, regardless of the initial pre-
entation. Interestingly, the persistence of abnormal strain
atterns might reflect the inadequacy of standard medical
are. This hypothesis would be consistent with recent data
hat indicate the need for intensive intervention for LDL-C
70 mg/dl) and inflammation (C-reactive protein 2
g/l) to achieve the best clinical outcomes in the course of
herapy with statins in post-ACS patients (26,27).
Prior studies suggest that gray-scale echogenicity is re-
ated to the histological components of carotid and coronary
laques (28–30). Although carotid plaque echogenicity can
e assessed noninvasively, assessment of coronary plaque
chogenicity requires invasive techniques and has been
estricted to research settings. In the present study, we used
quantitative computer-assisted index of echogenicity, on
he basis of gray-scale values of adventitia, and demon-
trated that hypoechogenic tissue was the predominant
laque component. We found no significant change in
bsolute hypoechogenic or hyperechogenic PV over the
verage six months. Our findings differ from the observa-
ions of Schartl et al. (31), who found a small but significant
ncrease in the hyperechogenic plaque component; however,
heir study had a longer follow-up period and patients had
ntensive, carefully monitored, statin therapy. A recent study
onducted at our institution suggested that the changes in
laque echogenicity require a much longer period to occur
more than two years) (32). Accordingly, the high prepon-
erance of hypoechogenic plaque (90% of the PV) cou-
able 6. Plaque Characterization With Palpography
n  49 Patients/52 Vessels)
Palpography
Number of
High Strain Spots
Density of
High Strain Spots
otal population (n  52)
Baseline 4.8  4.5 1.6  1.5
Follow-up 3.6  4.4 1.2  1.4
p value 0.009 0.0123
TEMI (n  12)
Baseline 7.2  5.8 2.3  1.8
Follow-up 3.8  4.6 1.1  1.4
p value 0.003 0.0003
A or non–STEMI (n  16)
Baseline 4.1  3.9 1.8  1.8
Follow-up 3.1  3.5 1.4  1.7
p value 0.17 0.29
table angina (n  24)
Baseline 4.0  4.0 1.2  1.1
Follow-up 3.8  4.9 1.2  1.1
p value 0.69 0.56
alues are expressed using the total number and density of high strain spots, given as
ean  SD. Density refers to the number of Rotterdam Classification 3/4 spots per0 mm of vessel.
STEMI  ST-segment elevation myocardial infarction; UA  unstable angina.
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The IBIS Study March 21, 2006:1134–42igure 3. Example of multimodality coronary imaging of the proximal left anterior descending coronary artery. (A, B) Region of interest (ROI) is defined
y the ostium of the left anterior descending and a large septal branch, as marked by white lines on the conventional angiogram (A) and arrowheads on
ultislice computed tomography maximum intensity projection reconstruction (B). (C) Gated longitudinal intravascular ultrasound (IVUS) reconstruction.
he vertical lines mark the boundaries of the ROI. The red line indicates the lumen-intima interface and the green line the external border of the plaque
lus echolucent media. (D, E) Representative color-coded cross-sectional palpograms that are superimposed on the IVUS image. Strain values are
olor-coded from 0% (blue) to 2% (yellow), as shown on the vertical scale. (D) Shows non-deformable eccentric plaque with calcification and acoustic
hadowing. The blue line around the lumen indicates a non-deformable plaque with 0% strain. In the regions without plaque, the gray color indicates that
o strain value can be measured. (E) Shows eccentric partly calcified plaque with a high strain (yellow) spot on one shoulder of the plaque (nine o’clock).
n the other shoulder (four o’clock) the blue color (0% strain) indicates that the plaque is not deformable in this region. (F, G) Representative color-coded
chogenicity cross sections. Hypoechogenic tissue is represented in red and hyperechogenic tissue in green. (F) Shows a cross section with a relatively large
yperechogenic area. The white spots visible most likely represent thick fibrous tissue and not calcification, because there was no acoustic shadowing on
he corresponding IVUS images (not shown). (G) Shows a cross section, which predominantly contains hypoechogenic tissue. (H) Multislice computed
omography reconstruction and (inset) a cross section in an area with calcified plaque (arrows).
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March 21, 2006:1134–42 The IBIS Studyled with the lack of significant change during the short-
erm follow-up suggests that plaque echogenicity lacks the
iscrimination necessary either for risk stratification or as a
urrogate measure of plaque composition on serial studies.
tudy limitations. This observational study has limita-
ions. First, our patient population was intentionally hetero-
eneous, and the study was underpowered to correlate
ompositional imaging end points with clinical outcomes.
lthough follow-up was incomplete (67 of 84, 80%), it
ompares favorably with recent serial IVUS studies (33,34).
oreover, baseline characteristics of the 67 patients with
ompleted follow-up were the same as in the overall study
opulation. Second, the present study did not demonstrate
hanges in plaque size. By contrast, recently published
tudies demonstrated regression of coronary atherosclerosis
n patients with acute coronary syndromes treated with
ggressive statin regimen (34). In contrast, in those with
table coronary artery disease maximal dose of atorvastatin
iven for 18 months only halted plaque growth (33).
otential explanation for these disparate results may be due
o different duration of follow-up (6 vs. 18 months),
nderlying index event (stable vs. acute coronary syndrome),
r suboptimal intensity of statin treatment noted in many
BIS patients that reflects slow adoption of current guide-
ines into clinical practice settings. With these caveats,
owever, data from recent trials, such as Reversing Athero-
clerosis with Aggressive Lipid Lowering (REVERSAL)
nd Pravastatin or Atorvastatin Evaluation and Infection
herapy (PROVE-IT), indicate that intensive treatment
ith statins affects plaque size and event rates, respectively
33,35). Third, although our results underscore the hetero-
eneity of coronary atheroma, much larger studies are
eeded to ultimately define the role of novel plaque imaging
echniques in clinical practice. Fourth, our attempt to relate
irculating biomarkers to coronary plaque imaging in an
rbitrarily selected ROI can only be regarded as exploratory.
e did not further discuss this possible interaction because
he correlations we found were weak. Fifth, the suboptimal
patial and temporal resolution of the 16-slice MSCT
canner precludes accurate assessment of coronary artery
egments2 mm. Although the ROI as selected by MSCT
as chosen randomly, distal coronary segments are inevita-
ly underrepresented. The same argument holds true, how-
ver, for IVUS examination of the coronary tree, where for
afety reasons only the larger coronary segments are targeted
or interrogation.
onclusions. Mild angiographic disease is associated with
arge atherosclerotic plaques identified with noninvasive
SCTA. This study also confirms that conventional inva-
ive imaging modalities frequently reveal static luminal and
laque dimensions, whereas novel IVUS-based plaque pal-
ography can detect significant alterations in coronary
laque characteristics over a relatively short time interval.
ur results highlight the dynamic changes in the strain of
oronary plaques that are remote from the culprit lesions,
articularly in patients with MI. Whether the persistence ofhigh-strain pattern is a harbinger of cardiovascular events
emains to be determined in much larger future studies. The
ovel imaging modalities used in this study provide insights
nto plaque biology, whereas temporal changes detected
ith these modalities might eventually serve as intermediate
nd points in interventional trials.
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